FHTX vs PCAR · rev $19.3M vs P/E 25, rev $33.66B
Foghorn Therapeutics Inc (FHTX) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
FHTX currently screens at market cap $237.8M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the FHTX and PCAR stock pages for the full models.
Not investment advice.